Current Medicinal Chemistry - Central Nervous System Agents

Preface
pp. i-i(1)
Author: Hamilton, G.S.

Glutamate mGlu5-Adenosine A2A-Dopamine D2 Receptor Interactions in the Striatum. Implications for Drug Therapy in Neuro-psychiatric Disorders and Drug Abuse
pp. 1-26(26)
Authors: Ferre, S.; Ciruela, F.; Woods, A.S.; Canals, M.; Burgueno, J.; Marcellino, D.; Karcz-Kubicha, M.; Hope, B.T.; Morales, M.; Popoli, P.; Goldberg, S.R.; Fuxe, K.; Lluis, C.; Franco, R.; Agnati, L.

Serotonin Type-4 (5-HT4) Receptors as Therapeutic Targets: Past and Future Roles of 5-HT4 Receptor Agonists
pp. 27-36(10)
Authors: Mattes, H.; Pfannkuche, H-J.

Serotonin Type-4 (5-HT4) Receptors as Therapeutic Targets: 5-HT4 Receptor Antagonists
pp. 37-42(6)
Authors: Mattes, H.; Pfannkuche, H-J.

New Approaches in the Treatment of Overactive Bladder: Targeting Adrenergic Receptors and Neurokinin Receptors
pp. 43-47(5)
Author: Ishizuka, O.

The Therapeutic Potential of Amphetamines in Post-stroke Recovery
pp. 49-55(7)
Authors: Khokar, A.; Kirmani, J.F.; Xavier, A.R.; Qureshi, A.I.

Membrane Pathology in Schizophrenia: Implication for Arachidonic Acid Signaling
pp. 57-65(9)
Authors: Yao, J.K.; Reddy, R.D.

Author Index To Volume 2
pp. 67-67(1)
Author: Bentham, S.

subject Index To Volume 2
pp. 69-71(3)
Author: Bentham, S.